Gsa Capital Partners LLP Karuna Therapeutics, Inc. Transaction History

Gsa Capital Partners LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$191.53 - $236.82 $430,367 - $532,134	-2,247 Reduced 51.99%	2,075 $408,000
Q3 2022 Nov 14, 2022	SELL	$123.79 - $277.42 $67,341 - $150,916	-544 Reduced 11.18%	4,322 $972,000
Q2 2022 Aug 09, 2022	BUY	$93.97 - $143.33 $457,258 - $697,443	4,866 New	4,866 $616,000
Q2 2021 Aug 05, 2021	SELL	$107.45 - $135.95 $354,477 - $448,499	-3,299 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$95.46 - $133.08 $1,336 - $1,863	14 Added 0.43%	3,299 $397,000
Q4 2020 Feb 03, 2021	BUY	$75.23 - $109.23 $247,130 - $358,820	3,285 New	3,285 $334,000
Q3 2019 Nov 12, 2019	SELL	$16.05 - $27.35 $497,550 - $847,850	-31,000 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$20.02 - $20.02 $620,620 - $620,620	31,000 New	31,000 $621,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.